A national strategy for waiting-times research?
Slaughter PM, Carlisle J, Williams J, Ferris LE. CMAJ. 2005; 172(10):1283-4.
Publications
Are rates of gastrointestinal bleeding higher following the introduction of COX-2 inhibitors?
Mamdami M. Expert Opin Drug Saf. 2005; 4(3):591-8.
Time trends and geographic disparities in acute complications of diabetes in Ontario, Canada
Booth GL, Hux JE, Fang J, Chan BT. Diabetes Care. 2005; 28(5):1045-50.
The 2003 Canadian recommendations for dyslipidemia management: revisions are needed
Manuel DG, Tanuseputro P, Mustard CA, Schultz SE, Anderson GM, Ardal S, Alter DA, Laupacis A. CMAJ. 2005; 172(8):1027-31.
Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993–2000
Simunovic M, Thériault ME, Paszat L, Coates A, Whelan T, Holowaty E, Levine M. Can J Surg. 2005; 48(2):137-42.
New thyroxine treatment in older adults beginning lithium therapy: implications for clinical practice
Shulman KI, Sykora K, Gill SS, Mamdani M, Anderson G, Marras C, Wodchis WP, Lee PE, Rochon P. Am J Geriatr Psychiatry. 2005; 13(4):299-304.
Identifying individuals with reduced GFR using ambulatory laboratory database surveillance
Garg AX, Mamdani M, Juurlink DN, van Walraven C; Network of Eastern Ontario Medical Laboratories (NEO-MeL). J Am Soc Nephrol. 2005; 16(5):1433-9. Epub 2005 Mar 30.
Long-term outcomes of regional variations in intensity of invasive vs. medical management of Medicare patients with acute myocardial infarction
Stukel TA, Lucas FL, Wennberg DE. JAMA. 2005; 293(11):1329-37.
A voluntary privacy standard for health services and policy research: legal, ethical and social policy issues in the Canadian context
Weisbaum KM, Slaughter PM, Collins PK. Health Law Rev. 2005; 14(1):42-6.
The changing landscape for COX-2 inhibitors: a summary of recent events
Mamdani M. Healthc Q. 2005; 8(2):24-6.